Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.torrentpharma.com | |
Market Cap | 65,264.13 Cr. | |
Enterprise Value(EV) | 69,989.97 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 37.23 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 51.80 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 38.47 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 194.30 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 9.92 | Calculated using Price: 1,928.35 |
Dividend Yield | 1.14 | Period Ending 2023-03 |
No. of Shares Subscribed | 33.84 Cr. | 338,445,440 Shares |
FaceValue | 5 | |
About Torrent Pharmaceuticals Ltd. | ||
Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM. |
1 Day |
|
+3.36% |
1 Week |
|
+2.86% |
1 Month |
|
-1.47% |
3 Month |
|
-1.28% |
6 Month |
|
+24.93% |
1 Year |
|
+29.00% |
2 Year |
|
+24.20% |
5 Year |
|
+133.71% |
10 Year |
|
+777.72% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 34.19 | 57.92 | 23.80 | 15.12 | 9.34 | 21.47 | 23.49 | 13.18 | 20.50 | |
Return on Capital Employed (%) | 26.98 | 45.63 | 20.36 | 13.81 | 9.75 | 15.28 | 17.62 | 14.35 | 20.32 | |
Return on Assets (%) | 11.71 | 20.89 | 10.28 | 5.81 | 3.15 | 7.50 | 9.20 | 5.92 | 9.20 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 1,902 | 2,491 | 3,494 | 4,350 | 4,622 | 4,724 | 4,823 | 5,837 | 5,953 | 6,198 | |
Non Curr. Liab. | 927 | 2,505 | 1,995 | 2,303 | 4,142 | 3,861 | 3,299 | 2,924 | 2,238 | 2,823 | |
Curr. Liab. | 2,175 | 2,824 | 3,285 | 2,738 | 5,202 | 5,165 | 5,454 | 4,892 | 4,415 | 5,447 | |
Minority Int. | 0 | 0 | 0 | 0 | 1 | ||||||
Equity & Liab. | 5,004 | 7,820 | 8,775 | 9,392 | 13,967 | 13,751 | 13,577 | 13,653 | 12,606 | 14,468 | |
Non Curr. Assets | 1,600 | 3,768 | 4,086 | 4,513 | 8,705 | 8,714 | 8,596 | 8,130 | 7,312 | 9,139 | |
Curr. Assets | 3,404 | 4,051 | 4,680 | 4,879 | 5,262 | 5,038 | 4,979 | 5,522 | 5,165 | 5,314 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 5,004 | 7,820 | 8,775 | 9,392 | 13,967 | 13,751 | 13,577 | 13,653 | 12,606 | 14,468 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 4,653 | 6,667 | 5,816 | 5,950 | 7,673 | 7,939 | 8,005 | 8,508 | 9,620 | 9,864 | |
Other Income | 286 | 229 | 223 | 307 | 64 | 121 | 57 | 197 | 63 | 49 | |
Total Income | 4,939 | 6,896 | 6,039 | 6,257 | 7,736 | 8,061 | 8,061 | 8,705 | 9,683 | 9,913 | |
Total Expenditure | -3,633 | -3,937 | -4,438 | -4,609 | -5,696 | -5,769 | -5,524 | -6,077 | -6,796 | -6,943 | |
PBIDT | 1,306 | 2,959 | 1,601 | 1,648 | 2,040 | 2,292 | 2,537 | 2,628 | 2,887 | 2,970 | |
Interest | -175 | -184 | -206 | -308 | -504 | -451 | -353 | -255 | -333 | -381 | |
Depreciation | -191 | -238 | -307 | -409 | -618 | -654 | -658 | -662 | -707 | -743 | |
Taxation | -189 | -610 | -155 | -253 | -125 | -162 | -274 | -449 | -602 | -586 | |
Exceptional Items | -194 | -357 | -485 | ||||||||
PAT | 751 | 1,733 | 934 | 678 | 436 | 1,025 | 1,252 | 777 | 1,245 | 1,260 | |
Minority Interest | 0 | 0 | 0 | 0 | 0 | ||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 751 | 1,733 | 934 | 678 | 436 | 1,025 | 1,252 | 777 | 1,245 | 1,260 | |
Adjusted EPS | 22 | 51 | 28 | 20 | 13 | 30 | 37 | 23 | 37 | 37 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 599 | 810 | 2,742 | 1,009 | 894 | 1,798 | 1,393 | 2,005 | 1,803 | 2,368 | |
Cash Fr. Inv. | -356 | -2,162 | -838 | -787 | -4,707 | -241 | 199 | -449 | -197 | -2,415 | |
Cash Fr. Finan. | 86 | 1,212 | -1,435 | -193 | 3,417 | -1,314 | -1,549 | -1,651 | -1,781 | 77 | |
Net Change | 330 | -140 | 469 | 29 | -395 | 242 | 42 | -95 | -175 | 30 | |
Cash & Cash Eqvt | 955 | 865 | 1,050 | 1,068 | 702 | 940 | 662 | 573 | 398 | 509 |
Sat, 30 Sep 2023
Announcement under Regulation 30 (LODR)-Change in Management Intimation regarding Change in Senior Management Personnel of the Company |
Fri, 29 Sep 2023
Closure of Trading Window Intimation of the Closure of Trading Window |
Thu, 21 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of Loss of Share Certificates |
Fri, 29 Sep 2023 |
|
|
|
|
|